Antimitogenic effects of trapidil in coronary artery smooth muscle cells by direct activation of protein kinase A

Molecular Pharmacology

Volumn 54, Issue 2, 1998, Pages 241-248

  Bönisch, Detlef ^a   Weber, Artur Aron ^a   Wittpoth, Michael ^a   Osinski, Michael ^a   Schrör, Karsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL ESTER; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RAF PROTEIN; TRAPIDIL;

ANIMAL CELL; ARTICLE; BLOOD VESSEL INJURY; CATTLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 0031848016     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.2.241     Document Type: Article

References (38)

1. Bartel S, Tenor H, and Krause EG (1985) Trapidil derivatives as potent inhibitors of cyclic AMP phosphodiesterase from heart and coronary arteries. Biomed Biochim Acta 44:K31-K35.
2. Bradford M (1976) A rapid and sensitive method for the quantification of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Carroll MP and May WS (1994) Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine hematopoietic cells. J Biol Chem 269:1249-1256.
4. Cercek B, Ebrahimi R, Dimayuga P, Khorsandi M, and Forrester JS (1991) Trapidil prevents rat vascular smooth muscle cell proliferation in vitro and in vivo. J Am Coll Cardiol 17:72A.
5. Claesson-Welsh L (1994) Platelet-derived growth factor receptor signals. J Biol Chem 269:32023-32026.
6. Cook SJ and McCormick FM (1993) Inhibition by cAMP of Ras-dependent activation of Raf. Science (Washington DC) 262:1069-1072.
7. Davis RJ (1993) The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553-14556.
8. Graves LM, Bornfeldt KE, Raines EW, Potts BC, MacDonald SG, Ross R, and Krebs EG (1993) Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci USA 90:10300-10304.
9. 2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen. Eur J Pharmacol 319:327-332.
10. Halbrügge M, Friedrich C, Eigenthaler M, Schanzenbacher P, and Walter U (1990) Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cAMP-and cAMP-elevating vasodilators. J Biol Chem 265:3088-3093.
11. Harder S, Thürmann PA, Hellstern A, and Benjaminov A (1996) Pharmacokinetics of trapidil, an antagonist of platelet-derived growth factor, in healthy subjects and in patients with liver cirrhosis. Br J Clin Pharmacol 42:443-449.
12. Heinroth-Hoffmann I, Krüger J, Tertov VV, Orekhov AN, and Mest H-J (1990) Influence of trapidil and trapidil derivatives on the content of cyclic nucleotides in human intima cells cultured from atherosclerotic plaques. Drug Dev Res 19:321-327.
13. Hoshiya M and Awazu M (1998) Trapidil inhibits platelet-derived growth factor-stimulated mitogen-activated protein kinase cascade. Hypertension 31:665-671.
14. Indolfi C, Avvedimento EV, Di-Lorenzo E, Esposito G, Rapacciuolo A, Giuliano P, Grieco D, Cavuto L, Stingonge AM, Ciullo I, Condorelli G, and Chiarello M (1997) Activation of cAMP-PKA signalling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat Med 3:775-779.
15. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, and Rapp U (1993) Protein kinase C-α activates RAF-1 by direct phosphorylation. Nature (Lond) 364:249-252.
16. Liu MW, Roubin GS, Robinson KA, Black AJR, Hearn JA, Siegel RJ, and King III SB (1990) Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation 81:1089-1093.
17. Malarkey K, Belham CM, Paul A, Graham A, McLees A, Scott PH, and Plevin R (1995) The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem J 309:361-375.
18. Maresta A, Balducelli M, Cantini L, Casari A, Chioin R, Fabbri M, Fontanelli A, Monici Preti PA, Repetto S, De Servi S, and Varani E (1994) Trapidil (Triazolopyrimidine), a platelet derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Circulation 90:2710-2715.
19. Markert T, Krenn V, Leebmann J, and Walter U (1996) High expression of the focal adhesion-and microfilament-associated protein VASP in vascular smooth muscle and endothelial cells of the intact human vessel wall. Basic Res Cardiol 91:337-343.
20. Marquart B, Frith D, and Stabel S (1994) Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9:3213-3218.
21. Mazurov AV, Menshikov MY, Leytin VL, Tkachuk VA, and Repin VS (1984) Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil. FEBS Lett 172:167-171.
22. McKenzie F and Pouysségur J (1996) cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. J BM Chem 271:13476-13483.
23. Morrison D, Kaplan DR, Rapp U, and Roberts TM (1988) Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase RAF-1 phosphorylation and associated protein kinase activity. Proc Natl Acad Sci USA 85:8855-8859.
24. Mullins D, Hamud F, Reim R, and Davis HR (1994) Inhibition of PDGF receptor binding and PDGF-stimulated biological activity in vitro and of intimal lesion formation in vivo by 2-bromomethyl-5-chlorobenzene sulfonylphthalimide. Arterioscler Thromb 14:1047-1055.
25. 2 synthesis in human umbilical veins perfused in vitro. Prostaglandins 49:311-318.
26. Nishikawa H, Ono N, and Motoyasu M (1992) Preventive effects of trapidil (PDGF antagonist) on restenosis after PTCA. Circulation 86:1-53.
27. Noguchi K, Tomoike H, Kawachi Y, Nabeyama S, Shimokawa H, Maruoka Y, and Nakamura N (1984) Effects of trapidil and nitroglycerin on coronary circulation in conscious dogs. Arzneim-Forsch 34:872-876.
28. Obata H, Biro S, Arima N, Kaieda H, Kihara T, Eto H, Miyata M, and Tanaka H (1996) NF-kappa B is induced in the nuclei of cultured rat aortic smooth muscle cells by stimulation of various growth factors. Biochem Biophys Res Commun 224:27-32.
29. Ohnishi H, Yamaguchi K, Shimada S, Suzuki Y, and Kumagi A (1982) A new approach to treatment of atherosclerosis and trapidil as an antagonist to plateletderived growth factor. Life Sci 31:2595-2602.
30. Okamoto S, Inden M, Setsuda M, Konishi T, and Nakano T (1992) Trapidil (triazolopyrimidine), a platelet-derived growth factor (PDGF) antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 123:1439-1444.
31. Post GR and Brown JH (1996) G-protein-coupled receptors and signaling pathways regulating growth responses. FASEB J 10:741-749.
32. Reines EW and Ross R (1993) Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 69:S30-S37.
33. Ross R and Fuster V (1996) The pathogenesis of atherosclerosis, in Atherosclerosis and Coronary Artery Disease (Fuster V, Ross R, and Topol EJ, eds) pp 411-460, Lippincott-Raven, Philadelphia.
34. Schröder H and Schrör K (1993) Prostacyclin-dependent cyclic AMP formation in endothelial cells. Naunyn-Schmiedebergs Arch Pharmacol 347:101-104.
35. Sharma RV and Bhalla RC (1993) PDGF-induced mitogenic signaling is not mediated through protein kinase C and c-fos pathway in VSM cells. Am J Physiol 264:C71-C79.
36. Sözeri O, Vollmer K, Liyanage M, Frith D, Kour G, Mark GE III, and Stabel S (1992) Activation of the c-Raf protein kinase by protein kinase C phosphorylation. Oncogene 7:2259-2262.
37. Tiell ML, Sussmann II, Gordon PB, and Sanders RN (1983) Suppression of fibroblast proliferation in vitro and of neointimal hyperplasia in vivo by the triazolopyrimidine, trapidil. Artery 12:33-50.
38. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, and Sturgill TW (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science (Washington DC) 262:1065-1069.